HAEMONETICS CORP PP&E Disclosure
| March 28, 2026 | March 29, 2025 | ||||||||||
| (Dollars in Thousands) | |||||||||||
| Land | $ | 2,251 | $ | 1,985 | |||||||
| Building and building improvements | 109,793 | 105,079 | |||||||||
| Plant equipment and machinery | 197,552 | 181,825 | |||||||||
| Office equipment and information technology | 131,085 | 130,924 | |||||||||
| Haemonetics equipment | 371,205 | 395,152 | |||||||||
| Construction in progress | 29,943 | 22,229 | |||||||||
| Property, plant and equipment, at cost | 841,829 | 837,194 | |||||||||
| Less: accumulated depreciation | (536,068) | (553,142) | |||||||||
| Property, plant and equipment, net | $ | 305,761 | $ | 284,052 | |||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2026 | May 20, 2026 | Showing above |
| 2025 | May 21, 2025 | |
| 2024 | May 20, 2024 | |
| 2023 | May 22, 2023 | |
| 2022 | May 25, 2022 | |
| 2021 | May 26, 2021 | |
| 2020 | May 20, 2020 | |
| 2019 | May 22, 2019 | |
| 2018 | May 23, 2018 | |
| 2017 | May 24, 2017 | |
| 2016 | Jun 1, 2016 | |
About PP&E Disclosures
The PP&E disclosure details a company's physical asset base — land, buildings, machinery, and equipment — along with the depreciation methods and useful life assumptions that determine how these costs flow through the income statement. Capitalization policy thresholds reveal management's judgment on the boundary between expense and asset, directly affecting both reported earnings and asset values.
Key signals: changes in estimated useful lives or depreciation methods can materially shift reported earnings without any operational change. Compare capital expenditures against depreciation expense — when capex consistently trails depreciation, the asset base may be aging and underinvested. Watch for large asset impairments or write-downs that signal overvalued carrying amounts. Asset retirement obligations reveal future environmental or decommissioning costs that are often underappreciated. Compare PP&E intensity (PP&E-to-revenue) against industry peers to assess capital efficiency and competitive positioning.